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Abstract
Introduction
Tobacco exposure has been linked with sinonasal pathology and may be associated with
allergic sensitization. This study evaluates the association between exposure to active
smoking or secondhand smoke (SHS) and the prevalence of rhinitis and allergic sensitiza-
tion in the US adult population.
Methods
Cross-sectional study in 4,339 adults aged 20–85 in the National Health and Nutrition
Examination Survey, 2005–2006. Never smoking was defined as reported lifetime smoking
less than 100 cigarettes and serum cotinine levels <10ng/ml, while active smoking was
defined as self-reported smoking or serum cotinine concentrations > 10 ng/mL. Self-
reported rhinitis was based on symptoms during the past 12 months, and allergen sensitiza-
tion was defined as a positive response to any of the 19 specific IgE antigens tested.
Results
Almost half of the population (43%) had detectable levels of IgE specific to at least one
inhaled allergen and 32% reported a history of rhinitis. After multivariate adjustment, there
was a statistically significant association between the highest serum cotinine tertile and rhi-
nitis in active smokers (OR 1.42; 95%CI 1.00–2.00). The association between active smok-
ing and rhinitis was stronger in individuals without allergic sensitization (OR 2.47; 95%CI
1.44–4.23). There was a statistically significant association between increasing cotinine ter-
tiles and decreased odds of inhaled allergen sensitization (p-trend <.01).
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Conclusion
Tobacco smoke exposure was associated with increased prevalence of rhinitis symptoms,
but not with allergic sensitization. The results indicate that the relationship between tobacco
smoke exposure and sinonasal pathology in adults may be independent of allergic
sensitization.
Introduction
Allergic sensitization is common in the US population and is a predisposing factor for multiple
respiratory conditions[1]. Those conditions, including asthma and allergic rhinitis, can greatly
affect an individual’s quality of life, and incur a substantial economic burden. In the United
States, the total direct annual cost of allergic rhinitis alone has been shown to be as high as 3.4
billion dollars[2]. Allergic sensitization and rhinitis are very common, with a reported preva-
lence of rhinitis symptoms as high as 44% in the US population[3]. Despite the scope of the
problem, few environmental risk factors have been identified for allergic sensitization or
rhinitis.
Notwithstanding the public health efforts, tobacco smoke exposure remains common and
has been linked with an increased risk of multiple upper respiratory conditions in various age
groups. Significant associations have been suggested between tobacco smoke exposure and
chronic sinusitis[4], asthma[5] and allergic rhinitis[6]. The data on associations between
tobacco smoke exposure and allergic sensitization, however, have been conflicting. Some stud-
ies have reported significant associations between IgE mediated allergic sensitization and
tobacco smoke[7], while others have reported either no association[8] or even an inverse asso-
ciation between allergic sensitization and tobacco smoke exposure[9]. This suggests that
tobacco exposure may predispose individuals to rhinitis, but the mechanism may or may not
involve an increased predisposition to allergic sensitization.
Despite the high incidence of both, tobacco exposure and multiple upper respiratory
ailments, there is still no clear understanding of the relation between tobacco exposure,
allergic sensitization, and rhinitis. Large-scale epidemiologic studies evaluating the associa-
tions between smoking exposure and these two conditions are lacking in the literature.
Therefore, this study aims to evaluate the association between exposure to active smoking or
secondhand smoke (SHS) and the prevalence of rhinitis and allergic sensitization in the US
adult population.
Materials and Methods
Between 2005–2006, the National Health and Nutrition Examination Survey (NHANES)
examined a US nationally representative sample by using a complex multistage sample design.
NHANES provides nationally representative cross-sectional data of the health status of the
civilian, non-institutionalized US population. After selection using a complex survey design,
participants were interviewed and examined. Older individuals, Mexican Americans and black
individuals were intentionally oversampled. Therefore, appropriate sample weights were used
to obtain weighted regression estimates, and the final results of our analyses are generalizable
to the US population[10]. The NHANES protocol was reviewed and approved by the National
Center for Health Statistics Institutional Review Board. Written informed consent was given
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by the participants for their clinical records to be used in a research study. The unweighted
response rate for adult participants during the NHANES 2005–2006 was 74%[11].
Study Population
For this study, we selected individuals20 years of age who participated in the NHANES
2005–2006 (N = 4,979). We then excluded participants with missing values in serum cotinine
(N = 495), allergic sensitization (N = 70) or rhinitis (N = 1), as well as those without informa-
tion on education level (N = 5) or BMI (N = 69). Participants included in the analyses were
similar with respect to the main socio-demographic variables when compared with the original
sample of adults surveyed (data not shown).
Exposure Assessment
Serum cotinine is a metabolic byproduct of nicotine, and has been demonstrated as an accurate
measure of recent nicotine exposure. The half-life of cotinine is approximately 17 hours, allow-
ing time for detection of recent nicotine exposure[12]. Serum cotinine was measured by an iso-
tope dilution-high performance liquid chromatography/atmospheric pressure chemical
ionization tandem mass spectrometry [CDC]. The limit of detection (LOD) for serum cotinine
was 0.015 ng/mL. Serum cotinine concentrations below the LOD were replaced by the LOD
divided by the square root of 2. Because serum cotinine only allows for measurement of recent
nicotine exposure, past exposure data must still be obtained from self-report. Tobacco use and
exposure to second-hand smoke were assessed by using self-reported information and serum
cotinine. Participants were analyzed in two categories: Secondhand smoke (SHS) exposure and
active smoking. Within the SHS analysis, individuals who reported never smoking and had
serum cotinine levels below the level of detection were categorized as unexposed. Those who
reported never smoking and had serum cotinine levels above the level of detection, but< =
10ng/ml were divided into tertiles of serum cotinine. Within the active smoking analyses, indi-
viduals who reported smoking less than 100 cigarettes in their life and had serum cotinine lev-
els<10ng/ml were classified as never smokers. Those who reported smoking more than 100
cigarettes in their life but none in the last month and had serum cotinine<10ng/ml were classi-
fied as former smokers. The participants with serum cotinine> = 10ng/ml were then divided
into tertiles of serum cotinine levels.
Outcome Assessment
NHANES 2005–2006 collected information on allergic symptoms and sensitization. Serum
samples were analyzed for 19 allergen specific IgEs (Dermatophagoides farinae, Dermatopha-
goides pteronyssinus, cat, dog, cockroach, Alternaria alternata, peanut, egg, cow’s milk, rag-
weed, rye grass, bermuda grass, oak, birch, shrimp, Aspergillus fumigatus, Russian thistle,
mouse and rat) using the Pharmacia Diagnostics ImmunoCAP 1000 System (Kalamazoo, MI,
USA). The lower limit of detection for each of the allergen-specific IgE antibody tests was 0.35
kU/L. Allergen sensitization was defined as a positive response if the level of any of the 19 spe-
cific IgE antigens was above the lower limit of detection (0.35 kU/L). Additionally inhaled aller-
gen sensitization was defined as a positive response to Dermatophagoides farina,
Dermatophagoides pteronyssinus, cat, dog, cockroach, alternaria alternata, ragweed, rye grass,
Bermuda grass, oak, birch, Aspergillus fumigatus, Russian thistle, mouse, rat and food allergen
sensitization as a positive response to peanut, egg, cow's milk or shrimp specific IgEs. Self-
reported rhinitis was defined as an affirmative reply to the question “during the last 12 months
have you had a problem with sneezing, or a runny, or blocked nose when you did not have a
cold or the flu?”
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Adjustment variables
Questionnaire information included gender, age, education (less than high school, high school,
and more than high school), race/ethnicity (non-Hispanic white, non-Hispanic black, Mexican
American, other) and BMI (<25, 25–30,>30).
Statistics
Statistical analyses were performed in STATA version 11.2 statistical software (Stata Corp, Col-
lege Station, TX) by using the survey (svy) command to account for the complex sampling
design and weights in the NHANES.
The prevalence of allergic sensitization, inhalant allergen sensitization, food allergen sensiti-
zation and rhinitis was calculated overall and by sex, age, ethnicity, parental education and
BMI percentiles. We also estimated odds ratios (OR) and their 95% confidence intervals (95%
CI) to assess the association between tobacco smoke exposure and the studied outcome vari-
ables using logistic regression models. The relation between tobacco smoke exposure and self-
reported rhinitis, independent of allergic sensitization, was further explored by conducting a
separate analysis of only the individuals with no allergic sensitization. P-trend values were
computed by assigning the median concentration in each tertile to participants and evaluating
this as a continuous variable.
Results
A total of 4,339 individuals were included in the study. As shown in Table 1, approximately
43% of participants (N = 1,865) were sensitized to at least one aeroallergen and 32%
(N = 1,409) self-reported having rhinitis. Individuals who were male, black and in the youngest
age group were more likely to have allergic sensitization. Individuals who were male, black and
in the youngest age group were more likely to have allergic sensitization. Individuals with the
lowest education level were positive for fewer inhaled allergens, but more food allergens. Female,
white individuals, and individuals with greater than high school education showed a higher prev-
alence of rhinitis. There were no apparent differences in rhinitis or allergic sensitization preva-
lence between the education or BMI categories.
Results for the association between allergic sensitization, self-reported rhinitis and SHS
exposure are shown in Table 2. Three models are displayed: a univariate model (model 1), a
multivariate model adjusted for age and gender (model 2) and a multivariate model adjusted
for age, gender, ethnicity, education and BMI (model 3). A significant trend was apparent
between increasing cotinine levels and increased unadjusted odds of inhaled and food allergic
sensitization. However, this relation did not remain significant after multivariate adjustment.
There were no significant associations between SHS exposure categories and rhinitis. In a simi-
lar fashion, Table 3 shows the results for the active smoking analyses. Increasing exposure to
active smoking was significantly associated with decreased odds of inhaled allergen sensitiza-
tion in all 3 models (p-trend = .03 in model 1 and p-trend< .01 in models 2 and 3). Con-
versely, the highest tertile of serum cotinine was significantly associated with increased
multivariable-adjusted odds of self-reported rhinitis (OR 1.42; 95%CI 1.00–2.00). The trend,
however, was not significant in this analysis.
In order to further evaluate the relation between tobacco smoke exposure and rhinitis, inde-
pendent of allergic sensitization, we performed stratified analyses. Tables 4 and 5 show the
analyses of the relations between tobacco smoke exposure and rhinitis stratified by allergic sen-
sitization. Analyses of rhinitis and SHS are shown in Table 4, and those of rhinitis and active
smoking are shown in Table 5. A significant trend was observed between increasing cotinine
levels and decreasing odds of rhinitis in allergic sensitized individuals (p = .05). The interaction
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of SHS by sensitization categories, however, was not statistically significant (p-interaction =
.24). Non-sensitized individuals showed a significant trend of increasing multivariate-adjusted
odds of rhinitis with increasing serum cotinine levels (p< .01). Non-sensitized individuals in
the highest cotinine tertile had significantly higher odds of rhinitis than never-smokers (OR
2.47; 95%CI 1.44–4.23). The p-interaction between the allergic sensitization status and active
smoking the relation between tobacco smoke exposure and rhinitis was statistically significant
(p< .01).
Table 1. Allergic sensitization and self-reported rhinitis by participant characteristics in US adults (N = 4,339).
AS—Inhaled AS—Food AS–Inhaled and Food Self-reported Rhinitis
+ - + - + - + -
(N = 1865) (N = 2474) (N = 721) (N = 3618) (N = 637) (N = 3702) (N = 1409) (N = 2930)
Gender Male 54.8 43.1 60.2 45.9 62.8 45.8 44.9 49.8
Female 45.2 56.9 40.8 54.1 37.2 54.2 55.1 50.2
Age 20–38 45.5 30.4 38.7 34.9 39.5 34.9 33.4 36.6
39–53 32.4 31.2 31.1 31.8 32.8 31.5 34.2 30.3
54–85 25.1 38.4 30.2 33.3 27.7 33.6 32.4 33.1
Ethnicity White 67.9 75.7 61 74.4 59.8 74.3 78.9 68.8
Black 14.1 8.8 18.1 9.8 19.3 9.8 8.6 12.4
Mexican 8.4 7.9 9.8 7.8 10.2 7.8 5.3 9.6
Other 9.6 7.6 1.1 8 10.7 8.1 7.2 9.2
Education <HS 15.3 19.1 20 17 19.2 17.2 13 20
HS 24.2 25.2 24.3 24.9 24.2 24.9 22.4 26.1
>HS 60.5 55.7 55.7 58.1 56.6 57.9 64.6 53.9
BMI Normal 33.1 32.6 29.3 33.5 30.7 33.2 31.7 33.4
Overweight 33.7 32.5 34.5 32.7 34.1 32.8 32.3 33.3
Obese 33.2 34.9 36.1 33.8 35.2 34 36 33.2
doi:10.1371/journal.pone.0131957.t001
Table 2. Odds ratios and 95% confidence intervals for the association between tertiles of secondhand smoke (SHS) exposure, allergic sensitiza-
tion and rhinitis.
ALLERGIC SENSITIZ
INHALED
ALLERGIC
SENSITIZ FOOD
ALLERGIC SENSITIZ
INHALED+FOOD
RHINITIS
SELF-REPORT
N Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3
Unexposed
<0.011 778 1 1 1 1 1 1 1 1 1 1 1 1
Serum cotinine (ng/ml)
0.011–
0.031
0.96 0.93 0.86 1.22 1.4 1.08 1.21 1.12 1.06 0.87 0.89 0.92
0.011–
0.031
804 (0.85–
1.12)
(0.81–
1.08)
(0.66–
1.12)
(0.88–
1.69)
(0.85–
1.55)
(0.81–
1.46)
(0.81–
1.81)
(0.77–
1.62)
(0.74–
1.53)
(0.65–
1.16)
(0.66–
1.19)
(0.67–
1.27)
0.032–
0.086
1.07 1 0.99 1.36 1.24 1.15 1.43 1.27 1.19 0.99 1.02 1.09
0.032–
0.086
724 (0.85–
1.12)
(0.86–
1.17)
(0.71–
1.40)
(0.97–
1.89)
(0.91–
1.69)
(0.82–
1.60)
(0.94–
2.17)
(0.84–
1.92)
(0.76–
1.85)
(0.74–
1.33)
(0.76–
1.36)
(0.79–
1.49)
0.087–10 1.07 0.97 0.91 1.5 1.29 1.16 1.66 1.37 1.24 0.82 0.86 0.97
0.087–10 848 (0.89–
1.29)
(0.80–
1.17)
(0.61–
1.36)
(0.99–
2.26)
(0.87–
1.91)
(0.77–
1.74)
(1.05–
2.62)
(0.87–
2.16)
(0.78–
1.98)
(0.64–
1.06)
(0.67–
1.10)
(0.75–
1.26)
p-trend 0.95 0.99 0.84 0.07 0.25 0.51 0.03 0.17 0.35 0.21 0.37 0.8
doi:10.1371/journal.pone.0131957.t002
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Multiple sensitivity analyses were also performed. Results remained consistent when partici-
pants who had smoked during the 12 months prior to the study were considered as current
smokers. In addition, adjusting the multivariable analyses for pack years of smoking did not
change the results, nor did the adjusting for the presence of chronic obstructive pulmonary
Table 3. Odds ratios and 95% confidence intervals for the association between active tobacco smoking, allergic sensitization and rhinitis.
ALLERGIC
SENSITIZ INHALED
ALLERGIC
SENSITIZ FOOD
ALLERGIC SENSITIZ
INHALED+FOOD
RHINITIS
SELF-REPORT
N Model
1
Model
2
Model
3
Model
1
Model
2
Model
3
Model
1
Model
2
Model
3
Model
1
Model 2 Model
3
Never 2172 1 1 1 1 1 1 1 1 1 1 1 1
Former 982 0.76 0.83 0.87 0.91 0.9 0.97 0.92 0.94 1.02 1.08 1.09 1.02
(0.60–
0.95)
(0.64–
1.06)
(0.67–
1.10)
(0.72–
1.16)
(0.70–
1.16)
(0.76–
1.26)
(0.72–
1.21)
(0.70–
1.26)
(0.76–
1.38)
(0.87–
1.33)
(0.788–
1.36)
(0.82–
1.27)
Current
10–
143
442 0.97 0.77 0.8 1.1 0.94 0.97 1.17 0.96 0.99 0.76 0.81 0.85
(0.71–
1.31)
(0.56–
1.06)
(0.58–
1.11)
(0.80–
1.53)
(0.69–
1.30)
(0.71–
1.33)
(0.79–
1.74)
(0.66–
1.41)
(0.68–
1.44)
(0.87–
1.33)
(0.63–
1.03)
(0.67–
1.08)
144–
284
377 0.75 0.64 0.68 0.91 0.8 0.85 1.03 0.88 0.95 0.97 1.01 1.08
(0.61–
0.92)
(0.52–
0.80)
(0.54–
0.86)
(0.59–
1.39)
(0.51–
1.26)
(0.52–
1.36)
(0.66–
1.60)
(0.55–
1.42)
(0.56–
1.62)
(0.68–
1.38)
(0.70–
1.47)
(0.74–
1.57)
285 366 0.8 0.67 0.71 1.31 1.15 1.23 1.34 1.15 1.23 1.28 1.34 1.42
(0.59–
0.92)
(0.51–
0.93)
(0.51–
0.98)
(0.92–
1.87)
(0.81–
1.62)
(0.83–
1.85)
(0.93–
1.92)
(0.81–
1.63)
(0.81–
1.90)
(0.91–
1.79)
(0.96–
1.43)
(1.00–
2.00)
p-trend 0.03 <0.01 <0.01 0.19 0.62 0.96 0.11 0.77 0.5 0.57 0.33 0.18
Serum cotinine in ng/ml
Never smokers: participants who self-reported (“I have not smoked more than 100 cigarettes in life”) + did not have serum cotinine levels > = 10 ng/mL
Former smokers: participants who self-reported (“I have smoked more than 100 cig in life but I haven’t smoked in the last month”) + did not have serum
cotinine levels > = 10 ng/mL
Current smokers: participants who self-reported (“I have smoked more than 100 cig in life and I have smoked in the last month”) OR had serum cotinine
levels > = 10 ng/mL
doi:10.1371/journal.pone.0131957.t003
Table 4. Odds ratio and 95% confidence intervals for the association between secondhand smoke exposure and rhinitis by sensitization status.
Non sensitized adults Sensitized adults
N Model 1 Model 2 Model 3 N Model 1 Model 2 Model 3 p-Interaction*
Unexposed 432 1 1 1 346 1 1 1
SHS
0.011–0.031 461 1.2 1.25 1.4 343 0.57 0.57 0.91
(0.86;1.91) (0.92;2.00) (0.92;2.12) (0.35;0.91) (0.36;0.92) (0.37;1.01)
0.032–0.086 382 1.29 1.4 1.48 342 0.72 0.73 0.8
(0.85;1.97) (0.92;2.13) (0.94;2.32) (0.49;1.04) (0.50;1.07) (0.56;1.16)
0.087–10 446 1.02 1.15 1.31 402 0.62 0.63 0.73
(0.68;1.55) (0.75;1.75) (0.82;2.10) (0.40–0.94) (0.41;0.97) (0.47;1.14)
p-trend 0.91 0.47 0.2 0.05 0.08 0.28 0.24
*P interaction base on model 3
doi:10.1371/journal.pone.0131957.t004
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disease (COPD). A similar analysis to Table 5 performed in participants with a positive history
of asthma, showed a somewhat stronger association between rhinitis and smoking in non-sen-
sitized adults, suggesting a possibility that non-allergic individuals with both asthma and rhini-
tis may be prone to an even greater respiratory mucosal inflammatory response to tobacco
smoke than those without asthma.
Discussion
This study evaluated the association between exposure to active smoking or SHS and the preva-
lence of rhinitis and allergic sensitization in the US adult population. The prevalence of rhinitis
in our cohort was consistent with previous reports utilizing NHANES data[13,14] as well as
with other US nationwide surveys[3]. The assessment of tobacco smoke exposure in this study
was highly sensitive, assigning tobacco exposure to individuals with even very low levels of
serum cotinine. This method of assessing tobacco exposure in the NHANES dataset has been
previously described and the prevalence of exposure in this study was consistent with prior
reports[15]. Individuals identified as active smokers had a significantly higher prevalence of
rhinitis. This relationship did not appear to be due to allergic sensitization, as tobacco smoke
exposure was not significantly associated with allergic sensitization in the multivariate-adjusted
models. Sensitization to inhaled allergens was actually inversely related to cotinine levels in
active smokers. In addition, analyses stratified by sensitization status showed even stronger
associations between active tobacco smoke exposure and rhinitis among non-sensitized
participants.
Associations between tobacco smoke exposure and multiple respiratory diseases have previ-
ously been documented in the literature. In a 2011 study of 200 individuals, current as well as
past SHS exposure was found to be a significant risk factor for allergic rhinitis[16]. Likewise,
both active smoking and SHS have demonstrated a significant association with an increased
prevalence of chronic rhinosinusitis[4]. It has long been evident that smoking exposure is asso-
ciated with worse pulmonary function test results[17], but tobacco exposure has also been
shown to be associated with asthma[18], bronchitis[19], and chronic cough[20]. A 2006 study
of 77 bar employees prospectively evaluated before and after the introduction of a smoking ban
noted a significant improvement in multiple respiratory health measures following the ban
Table 5. Odds ratio and 95% confidence intervals for the association between active tobacco smoking and rhinitis by sensitization status.
Non sensitized adults Sensitized adults
N Model 1 Model 2 Model 3 N Model 1 Model 2 Model 3 p-interaction*
Never 1136 1 1 1 1036 1 1 1
Ever 585 1.21 1.2 1.12 397 1.05 1.07 1
(1.00–1.47) (0.97–1.50) (0.91–1.38) (0.75–1.46) (0.77–1.47) (0.72;1.41)
Current
10–143 237 0.96 1.29 1.15 205 0.62 0.63 0.69
(0.71–1.27) (0.88–1.88) (0.83–1.59) (0.40–0.95) (0.42–0.96) (0.46–1.02)
144–284 223 1.18 1.29 1.35 154 0.85 0.88 0.96
(0.83–1.70) (0.88–1.88) (0.88–2.07) (0.51–1.43) (0.52–1.49) (0.57–1.61)
285 209 2.06 2.29 2.47 157 0.74 0.77 0.78
(1.24–3.43) (1.17–1.88) (1.44–4.23) (0.48–1.15) (0.93–1.43) (0.54–1.11)
p-trend 0.02 <0.01 <0.01 0.09 0.09 0.13 <0.01
*P interaction base on model 3
doi:10.1371/journal.pone.0131957.t005
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[21]. Tobacco smoke exposure has been shown to modify the physiology of the normal respira-
tory tract, with demonstrated thickening of the lower airway walls, impairment of mucociliary
clearance, and alteration of the airway immune function[22]. The specific mechanism for the
relation between rhinitis and tobacco smoke exposure, however, has not been proven.
Although there is concern that allergic sensitization is a potential mechanism for develop-
ment of rhinitis in individuals exposed to tobacco smoke, our study found that the association
between rhinitis prevalence and tobacco smoke exposure may be independent of allergic sensi-
tization. This is consistent with other recent findings. A cross-sectional study of 18,087 individ-
uals in Sweden found a higher prevalence of allergic rhinitis associated with nonsmokers than
smokers, but a higher prevalence of chronic sinusitis and nasal congestion associated with a
positive smoking history[23]. These findings offer evidence that the mechanism linking smok-
ing and IgE mediated allergic sensitization may be distinct from those linking smoking with
rhinitis.
The relationship between allergic sensitization and tobacco smoke exposure is complex.
Past studies have observed significant associations between tobacco smoke and increased aller-
gic sensitization. On the other hand, evidence has also been shown for no association, or even
potentially reverse relationship between smoking exposure and mean IgE measurements[9]. A
32 year longitudinal study in New Zealand published in 2008 demonstrated no significant asso-
ciation between smoking exposure and allergic sensitization[24]. In addition, lower absolute
eosinophil counts have been observed in active smokers compared to never-smokers[25].
Results from studies looking at chronic airway inflammation have also suggested distinct eosin-
ophilic and non-eosinophilic phenotypes of inflammation, with potentially distinct clinical dis-
ease courses and responses to treatment[26]. One mechanism for the relation between rhinitis
and smoking may be neurogenic inflammation induced by cigarette smoke. Neurogenic
inflammation resulting from environmental exposures has been described in the literature and
represents an inflammatory mechanism distinct from that of allergic sensitization[27]. The
non-allergic etiology of nasal inflammation is further supported by multiple studies showing a
lack of association between aeroallergen sensitization and tobacco smoke exposure[8,28]. The
physiologic mechanism of the association observed in our study may also be the result of
immunosuppressive effects of tobacco smoke, as past work has demonstrated inhibition of
pro-inflammatory cytokines[29], reduction in serum levels of immunoglobulins, and inhibition
of T-cell activation[30] in tobacco-exposed individuals. In fact, it may be this same inflamma-
tory inhibition that leads to the documented increased incidence of various infections in indi-
viduals of all ages[31,32]. These mechanisms may explain the difference in the associations
with tobacco exposure between self-reported rhinitis and allergic sensitization in our study.
The strengths and limitations of our study should be considered. Data from NHANES are
comprehensive and nationally representative, drawing from a large and diverse sample of par-
ticipants. The NHANES tobacco smoke exposure measures have been shown to be objective
and reliable in past studies[15]. The study, however, is cross-sectional, and therefore causality
with respect to exposure variables cannot be determined. Rhinitis was self-reported, and so
may be prone to recall bias. However, we expect that recall bias would be similar in participants
exposed and those unexposed to tobacco smoke. Although multivariate adjusted models were
utilized in the analyses, there is also the possibility of residual confounding by unmeasured
factors. Reverse causation may also play a role, as individuals diagnosed with allergic sensitiza-
tion or respiratory conditions potentially actively avoiding further tobacco exposure. In our
study population, however, the prevalence of smoking exposure was high, and with a wide dis-
tribution of cotinine measurements, making this phenomenon less likely to affect the study
outcomes.
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Conclusions
This study demonstrated a significantly higher prevalence of self-reported rhinitis symptoms
in adult smokers, and this was observed to be independent of allergic sensitization. The results
of this study highlight the complex relationship between tobacco smoke exposure and sinona-
sal pathology, and suggest that the effect of smoking exposure on rhinitis symptoms may have
a mechanism distinct from allergic sensitization. Regardless of the mechanism, however, the
observed associations between rhinitis and smoking provide further evidence for the impor-
tance of minimizing tobacco smoke exposure.
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